149152-68-1

Basic information

• Product Name: (2S,4S)-1-tert-butyl 2-methyl 4-(((benzyloxy)carbonyl)amino)pyrrolidine-1,2-dicarboxylate
• Synonyms: (2S,4S)-1-tert-butyl 2-methyl 4-(((benzyloxy)carbonyl)amino)pyrrolidine-1,2-dicarboxylate
• CAS NO: 149152-68-1
• Molecular Weight: 378.425
• Mol File: 149152-68-1.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: (2S,4S)-1-tert-butyl 2-methyl 4-(((benzyloxy)carbonyl)amino)pyrrolidine-1,2-dicarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: (2S,4S)-1-tert-butyl 2-methyl 4-(((benzyloxy)carbonyl)amino)pyrrolidine-1,2-dicarboxylate(149152-68-1)
• EPA Substance Registry System: (2S,4S)-1-tert-butyl 2-methyl 4-(((benzyloxy)carbonyl)amino)pyrrolidine-1,2-dicarboxylate(149152-68-1)

Safety Data

• Hazardous Substances Data: 149152-68-1(Hazardous Substances Data)

Usage

Description

(2S,4S)-1-tert-butyl 2-methyl 4-(((benzyloxy)carbonyl)amino)pyrrolidine-1,2-dicarboxylate is a complex organic molecule characterized by a pyrrolidine ring structure. It features a tert-butyl group, a methyl group, a benzyloxycarbonylamino group, and two carboxylate groups. (2S,4S)-1-tert-butyl 2-methyl 4-(((benzyloxy)carbonyl)amino)pyrrolidine-1,2-dicarboxylate is likely to have pharmaceutical or biological applications due to its unique structure and functional groups. Its specific stereochemistry and substitution pattern may significantly influence its chemical and biological properties.

Uses

Used in Pharmaceutical Industry:
(2S,4S)-1-tert-butyl 2-methyl 4-(((benzyloxy)carbonyl)amino)pyrrolidine-1,2-dicarboxylate is used as a potential drug candidate for various therapeutic applications. Its unique structure and functional groups may contribute to its pharmacological activity, making it a promising molecule for the development of new medications.
Used in Chemical Synthesis:
(2S,4S)-1-tert-butyl 2-methyl 4-(((benzyloxy)carbonyl)amino)pyrrolidine-1,2-dicarboxylate is used as a building block for the synthesis of other complex organic compounds. Its specific stereochemistry and functional groups can be utilized in the creation of novel molecules with potential applications in various fields, including pharmaceuticals, materials science, and agrochemicals.

Upstream product

• 501-53-1 benzyl chloroformate 
• 121148-01-4 (2S,4S)-4-amino-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-methyl ester 
• 1217446-43-9 (2S,4S)-4-aminopyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-methyl ester hydrochloride 
• 84520-67-2 (2S,4R)-4-(methylsulfonyloxy)pyrrolidine-1,2-dicarboxylic acid 1-tert-butylester-2-methylester 
• 13726-69-7 (2S,4R)-4-hydroxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid 
• 74844-91-0 1-tert-butyl 2-methyl (2S,4R)-4-hydroxy-1,2-pyrrolidinedicarboxylate 
• 88043-21-4 (2S,4R)-4-(toluene-4-sulfonyloxy)-pyrrolidine-1,2-dicarboxylic acid 1-tert-butyl ester 2-methyl ester 
• 84520-68-3 N-tert-butoxycarbonyl-cis-4-azido-L-proline methyl ester 

Downstream Products

• 874162-99-9 (2S,4S)-4-(((benzyloxy)carbonyl)amino)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid 
• 1111791-42-4 N-Boc-cAmp-Leu-Phe-OMe 
• 1111791-46-8 N-Boc-cAmp(Boc)-Leu-Phe-OMe 
• 922139-40-0 tert-butyl (2S,4S)-4-amino-2-(hydroxymethyl)pyrrolidin-1-carboxylate 
• 1932593-75-3 tert-butyl (2S,4S)-4-(((benzyloxy)carbonyl)amino)-2-(hydroxymethyl)pyrrolidin-1-carboxylate 
• 1279038-33-3 C₁₄H₁₈N₂O₄*ClH 
• 185304-38-5 (2S,4S)-4-({(2S,4S)-4-Benzyloxycarbonylamino-1-[2-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-acetyl]-pyrrolidine-2-carbonyl}-amino)-1-[2-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-acetyl]-pyrrolidine-2-carboxylic acid methyl ester 
• 185304-45-4 (2S,4S)-4-Benzyloxycarbonylamino-1-[2-(5-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-acetyl]-pyrrolidine-2-carboxylic acid methyl ester 

Relevant articles and documents

ROR [gamma]t inhibitor, preparation method and application thereof

The invention relates to the technical field of medicines, in particular to an ROR [gamma]t inhibitor, a preparation method and application thereof. The invention also relates to a pharmaceutical composition containing the compound, a method for preparing the pharmaceutical composition, and application of the compound or the pharmaceutical composition in treatment or prevention of ROR [gamma]t-mediated cancers, inflammations or autoimmune diseases of mammals, especially human beings.

DNA POLYMERASE THETA INHIBITORS

The invention relates to heterocyclic derivatives and their use in the treatment and prophylaxis of cancer, and to compositions containing said derivatives and processes for their preparation.

IAP BIR domain binding compounds

A compound of Formula 1: (I) or salt thereof, as well as methods of making compounds of Formula 1, methods of using compounds of Formula 1 to treat proliferative disorders such as cancer, and related compounds, composition, and methods.